Member Info for stt1

Hobknob

"did they not also say contracts that are of material relevance. This is probably more about the new client and type of work than the £ amount. "

Did they?

Is it a coincidence the CEO's huge options start to exercise this month?

TwoGood2Die,

"why use a third party that pays itself huge bonuses using tax payers money while poaching valuable NHS doctors and nurses who can't be so easily replaced."

Again, posting misleading, incorrect information.

The govn has stated they are using more private providers.

Can you write to the govn telling them they are wrong?

Posting misleading information is market abuse, as it says at bottom of the message boxes.

"Important Message from the Financial Conduct Authority

Posting inside information that is not public knowledge, or information that is false or misleading, may constitute market abuse. "

Govn website:

https://www.gov.uk/government/news/deal-between-nhs-and-independent-sector-to-cut-nhs-waiting-lists#:~:text=The%20NHS%20and%20independent%20sector,at%20the%20point%20of%20use.

TwoGood2Die

"Bound to be other contracts cancelled soon "

The resilience contract wasn't cancelled, it was a 1 + 1 yr extension, so was due to end. You're posting misleading information.

The resilience contract was initially a 1yr contract, extended for another year. It was naturally due to end now.

16/01/2023 - TLY awarded the National resilience contract, worth c£10m, with a potential 1 year extension.

"initially for one year with the option to extend for a further year."

https://ir.design-portfolio.co.uk/viewer/100/55546

The extension ran for 12 months from 16/02/2024, so 6 weeks of the contract was in fy24 and the remaining in fy25.

10/01/2024 - TLY awarded the one year extension

"awarded a contract extension by NHS England to provide national NHS 111 contingency services for a further year."

"The contract, awarded to Vocare Limited ("Vocare"), part of Totally Urgent Care, will run for 12 months from 16 February 2024 at a value of c.£13 million per annum."

https://ir.design-portfolio.co.uk/viewer/100/61227

The contract came to a natural end, wasn't renewed. NHS England under Labour govn don't want to use a National resilience service. Tories did, Labour doesn't want to.

14/02/2025 - Today's update:

"The Company today announces that its NHS 111 National Resilience support contract (the "NHS 111 Contract") has not been renewed by NHS England and therefore will come to a conclusion on 15 February 2025. "

"This reflects NHS England's strategy to no longer provide resilience services (which support 111 pressures at a local level) at a national level."

https://ir.design-portfolio.co.uk/viewer/100/74794

When there was a void in contracts last year, some said it was because the company wasn't going to announce smaller contracts.

It's a £2m contract. The mcap is £122m. They need more than a small £2m contract to get revenue growth rate moving in the right direction.

The chairman dumped his entire holding at 28p/29p in 2 tranches. The 1st was over a year ago, the 2nd just 4 working days after the July TU.

I believe the chairman knows more about the company than anyone else.

He needs to buy back in. Until then he has set a ceiling on the valuation.

The resilience contract was initially a 1yr contract, extended for another year. It was naturally due to end now.

16/01/2023 - TLY awarded the National resilience contract, worth c£10m, with a potential 1 year extension.

"initially for one year with the option to extend for a further year."

https://ir.design-portfolio.co.uk/viewer/100/55546

The extension ran for 12 months from 16/02/2024, so 6 weeks of the contract was in fy24 and the remaining in fy25.

10/01/2024 - TLY awarded the one year extension

"awarded a contract extension by NHS England to provide national NHS 111 contingency services for a further year."

"The contract, awarded to Vocare Limited ("Vocare"), part of Totally Urgent Care, will run for 12 months from 16 February 2024 at a value of c.£13 million per annum."

https://ir.design-portfolio.co.uk/viewer/100/61227

The contract came to a natural end, wasn't renewed. NHS England under Labour govn don't want to use a National resilience service. Tories did, Labour doesn't want to.

14/02/2025 - Today's update:

"The Company today announces that its NHS 111 National Resilience support contract (the "NHS 111 Contract") has not been renewed by NHS England and therefore will come to a conclusion on 15 February 2025. "

"This reflects NHS England's strategy to no longer provide resilience services (which support 111 pressures at a local level) at a national level."

https://ir.design-portfolio.co.uk/viewer/100/74794

c6 weeks of the contract was in fy24 and the remaining recognised in current, fy25. They didn't lose c£1m as savage wrongly suggested, from the contract news, my reading is this was in fy24, March 2024.

"The value of the contract was c.£13 million, with c.£12 million being recognised in the current financial year. "

Any extension/new contract would have started around now, so obviously wouldn't impact the current fy25, March 2025. However, they were hoping for an extension for fy26, ending 31st March 2026, hence the adjustment for next year.

"The Company was not reliant on the extension of the NHS 111 Contract for the delivery of its FY25 forecast and therefore remains confident of delivering FY25 performance in line with expectations of £85 million revenue and £3.5 million EBITDA"

"The Board's financial expectations for the year ending 31 March 2026 did assume a renewal of the NHS 111 Contract, however at a reduced level. "

Nathan

"Wonder if we will see red flag STT today. Wonder if the red flags at TLY were ignored"

I've posted the company/sector newsflow, here and elsewhere. Read TLY newsflow.

By the way, HVO is trading closer to 10p than 30p, as I predicted, based on company newsflow.

Here, the chairman dumped his entire holding, that was one of many red flags.

I believe the chairman knows more about the company than any II/PI.

Here, they struggling to grow.

TLY c45% held by IIs.

The chairman and CFO buying.

c£85m revenues, higher than HVO

£3.5m ebitda

Mcap £11m, significantly lower than HVO's £120m

TwoGood2Die

"Nevermind Stt1 enjoy ramping this for another 20 years see where that leads you! All the best from the Nanoco team lol!"

After more than 2 years, you still bitter because you didn't understand basic news, which Nano rns'ed. I posted the facts and opinions based on those facts.

Try accepting responsibility for your own actions.

Lots of trader talk.

Seems like a lot of churning of trades going on.

Malbright

"I can remember the hype when we first dual listed on Nasdaq at the heady price of US$ 19 per share, with everybody thinking this would be they key to unlocking greater institutional investment (same line being peddled today as we transition to a full Nasdaq listing). That initial euphoria dissipated very rapidly over the next few months as results were absolutely pathetic."

Exactly.

Posters who were here before will remember what happened when they dual listed nearly 4 yrs ago. The shares dual listed at 800p, went to around 850p before crashing back on company newsflow, profit warning etc and the ad tech bubble bursting.

As per my assertion, they are already dual listed, a lot of investors are already aware of them. They will already be known by other companies within the ad tech ecosystem.

Not long before they delist from Aim.

Still no sign of any holding rns.

The opportunity to buy @ 7.8p has been there.

I don't think the 3m at 7.8p was any serious investor, probably a fake trade.

Skywalker

"There were many years where institutions were not buying "

Institution has been selling. Read the recent holding rns, JPM sold to below 3%. The main II buying was Octopus.

The chairman dumped his entire holding in July 2024, 4 working days after the July TU.

I believe the chairman knows more than any II/PI, don't you?

Solvista,

Well done.

Question is will Octopus follow and start selling down.

I wonder what JPM know.

Yes will be interesting to see who sold the 2x c18m shares.

Likely to be some II not happy.

Question is whether it's Octopus and if not, will they follow a sell as well

Mmhater

"Someone wants to buy a lot of shares and is after a deal"

Where's your evidence that someone WANTS to buy or IS after a deal?

There's still no TR-1. The last TR1 was months ago.

Solvista

"The 19 mil is the unaudited amount of revenue the 2 facilities earned in 2024.The guidance of £73 for 2025 includes CRS Mannheim and CRS Kiel!"

That's my understanding as well and what I posted earlier.

It shows revenue had they not bought the 2 units, would be significantly lower. The consequences of the revenue falling would have been far greater. The 2 units cloud the actuals.

Solvista

"Mo has lost alot of credibility"

I've been saying for over a year, when his huge options were awarded, they were backdated a year and start to exercise within a year, ie Feb 2025.

It's a red flag when huge options are awarded to 1 snr exec as it gives them the incentive to talk up the company.

"Peel Hunt has a target price of 34p, while Panmure Liberum's valuation is 24p (current price 19.08p)."

Peel Hunt, with 34p target, is company broker.

Panmure, with 24p target, is NOT company broker

The revenue guidance for 2025 is £73m. An increase of c£10m on £62.7m for fy2024.

This includes revenues from the acquisitions, which was c£16-17m for 2024 .

Therefore, without this acquisition, revenues would have fallen for 2025, as expected.

As per my assertions, the chairman dumped his entire holding last July, 4 working days after the July TU.

"Full year revenue guidance of £73 million in 2025 with EBITDA margins anticipated to be mid-high teens (excluding one-off costs)"

https://polaris.brighterir.com/public/hvivo/news/rns/story/ryn269w

Hallsworthy,

I'm highlighting that your valuation doesn't add up, given the acquisitions.

I did warn you of the red flags over a year ago, whilst you and others were ramping at 30p.

Hallsworthy

"To put it in context, the market is currently valuing us at around £81m when subtracting the current cash which is 1.1x revenue for 2025. Look at how peers are valued " "Look at how peers are valued and make your own mind up."

They just bought 2 units for 1/2 their 2024 revenue

From the rns:

" Total consideration of €10.0 million in cash, funded from hVIVO's existing cash resources

· The two units being acquired recorded revenue of €19.9 million in 2024 (unaudited) and €18.6 million in 2023"

https://polaris.brighterir.com/public/hvivo/news/rns/story/ryn269w